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Although the completion of genome project of the most
virulent malaria parasite Plasmodium falciparum in
2002 evoked great hopes for the identification of new
targets for novel drugs, these have not yet been fulfilled.
This disappointment and the successful use of natural
compounds emerging from traditional medicine for the
chemotherapy of malaria (quinine, artemisnin) have
invigorated the search for new antimalarials from nat-
ural sources. Hundreds of thousands compounds were
screened and some promising leads were identified.
However, the great advantage of traditional medicine is
a result of demonstrable synergism between the constitu-
ents of the crude extracts. The origin and the modes of
action of this synergism will be discussed. In conclusion,
it is suggested that greater emphasis should be given to
traditional medicine and some considerations for its con-
trolled implementation will be mentioned.
Published: 20 October 2010
doi:10.1186/1475-2875-9-S2-O16
Cite this article as: Ginsburg: Refreshed approaches to the therapy of
malaria - the case of natural medicine. Malaria Journal 2010 9(Suppl 2):
O16.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit Department of Biological Chemistry, Institute of Life Sciences, Hebrew
University of Jerusalem, Jerusalem, Israel
Ginsburg Malaria Journal 2010, 9(Suppl 2):O16
http://www.malariajournal.com/content/9/S2/O16
© 2010 Ginsburg; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.